• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Lampalizumab (CFD) Antibody – Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS1563302

MBS1563302 is an antibody targeting CFD. Also known as Research Grade Lampalizumab. Reactive in Human. More details

$560 / 0.1 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Lampalizumab (CFD), Monoclonal Antibody
Full Product Name
Research Grade Lampalizumab
Product Gene Name
Product Synonym Names
AFD; Anti-fD; Anti-FACTOR D; FCFD4514S; RG7417; PFD; Adipsin; C3 convertase activator; Complement factor D; CFD; DF; Properdin factor D
Clonality
Monoclonal
Species Reactivity
Human
Form/Format
Liquid. PBS buffer, pH7.4
Purity/Purification
>95%; Protein A or G purified from cell culture supernatant.
Concentration
1mg/ml (lot specific)
Preparation and Storage
Store at +4 degree C short term (1-2 weeks). Store at -20 degree C 12 months. Store at -80 degree C long term.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Molecular Weight
27,033 Da
Chromosome Location
Chromosome: 19; NC_000019.9 (859665..863624). Location: 19p13.3
OMIM
134350
3D Structure
ModBase 3D Structure for P00746
Host Species
Humanized
CAS
1278466-20-8

Product Categories/Family for anti-CFD antibody

ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for anti-CFD antibody
Research Grade Lampalizumab Biosimilar

Product References and Citations for anti-CFD antibody

Potential role of lampalizumab for treatment of geographic atrophy [Retraction], PMID: 26170604
Potential role of lampalizumab for treatment of geographic atrophy, PMID: 26089637
Emixustat and Lampalizumab: Potential Therapeutic Options for Geographic Atrophy, PMID: 26501510
Complement inhibition as a therapeutic strategy in retinal disorders, PMID: 30686077
Pharmacological Advances in the Treatment of Age-related Macular Degeneration, PMID: 31362645

Other Notes

Small volumes of anti-CFD antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for CFD. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
complement factor D preproprotein
NCBI Official Synonym Full Names
complement factor D (adipsin)
NCBI Official Symbol
CFD
NCBI Official Synonym Symbols
DF; ADN; PFD; ADIPSIN
UniProt Protein Name
Complement factor D
UniProt Synonym Protein Names
Adipsin; C3 convertase activator; Properdin factor D
Protein Family
UniProt Gene Name
CFD
UniProt Synonym Gene Names
DF; PFD
UniProt Entry Name
CFAD_HUMAN
NCBI Protein Information
complement factor D; properdin factor D; C3 convertase activator; complement factor D preproprotein; D component of complement (adipsin)

NCBI Summary for CFD

The protein encoded by this gene is a member of the trypsin family of peptidases. The encoded protein is a component of the alternative complement pathway best known for its role in humoral suppression of infectious agents. This protein is also a serine protease that is secreted by adipocytes into the bloodstream. Finally, the encoded protein has a high level of expression in fat, suggesting a role for adipose tissue in immune system biology. [provided by RefSeq, Jul 2008]
Show more

UniProt Comments for CFD

CFD: Factor D cleaves factor B when the latter is complexed with factor C3b, activating the C3bbb complex, which then becomes the C3 convertase of the alternate pathway. Its function is homologous to that of C1s in the classical pathway. Defects in CFD are the cause of complement factor D deficiency (CFDD). CFDD is an immunologic disorder characterized by increased susceptibility to bacterial infections, particularly Neisseria infections, due to a defect in the alternative complement pathway. Belongs to the peptidase S1 family.

Protein type: Protease; Secreted, signal peptide; EC 3.4.21.46; Secreted

Chromosomal Location of Human Ortholog: 19p13.3

Cellular Component: extracellular space; extracellular region

Molecular Function: serine-type peptidase activity; serine-type endopeptidase activity

Biological Process: platelet activation; platelet degranulation; complement activation, alternative pathway; innate immune response; blood coagulation; proteolysis; complement activation

Disease: Complement Factor D Deficiency
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000